Pharmaceutical company focused on development of treatments for obesity.
Sectors
Healthcare
Life Sciences
First Invested
2013
Public/PIPES
Company Status
IPO/Acquired
NASDAQ: OREX
Acquired by Nalpropion Pharmaceuticals
Associated Team
Website
Orexigen Therapeutics